The “most favored nation” policy would reduce the cost of domestic pharmaceuticals to the levels paid in Europe. The executive order also has a sister bill proposed for Congress that would solidify the rule into law.  

For the second time in less than two years, the struggling retail pharmacy chain has filed for Chapter 11 bankruptcy protection, seeking buyers as it prepares for store closures.

State Attorney General Dana Nessel is suing Express Scripts and Prime Therapeutics, accusing the two PBMs of manipulating rebate pricing, "crippling small, independent pharmacies and restricting access to lifesaving medications in the process."

A leaked report from Ernst & Young says President Donald Trump’s proposed 25% tariff on drugs would stifle domestic manufacturing and force the industry to take on an additional $51 billion in annual costs.

Ontario-based Andlauer Healthcare Group ships sensitive temperature-controlled products necessary for healthcare manufacturing and research. It has agreed to be acquired by the world’s largest courier, with the all-cash deal expected to close later this year. 

Two lots of Ropivacaine Hydrochloride Injection infusion bags from Amneal Pharmaceuticals are being removed from hospitals due to plastic fibers coming loose in the fluids.

The ongoing trade war between the United States and China could jeopardize the availability of contrast agents used for medical imaging. 

Certain PowerPICC Intravascular Catheters manufactured by BD and its subsidiary Bard Access Systems are to be removed from patient care settings immediately.